The Italian biotechnology industry has undergone extraordinary growth in large part due to excellent academic and industrial research and the ability of Italian companies to turn innovation into valuable products and technologies. Almost 500 biotech companies were active in Italy at the end of 2015, covering all fields of applications. Over half of these are dedicated biotech R&D firms.  

Market Facts

  • Rare disease and advanced therapy medicinal products are among areas of excellence of Italian biotechnology research.
  • 75% of Italy’s biotechnology companies are micro or small-sized organizations.

Italian Association for the Development of Biotechnology (Assobiotec)

Assobiotec, the Italian Association for the Development of Biotechnology, was born to foster, support and defend the development of biotechnology in all its various application fields, such as: human and animal healthcare (“red biotech”), agriculture and nutrition (“green biotech”), environment, processing industry, biomaterials, bioenergy, construction industry, restoration (“white biotech”).

Set up in 1986 within the Italian Federation of the Chemical Industry (Federchimica), Assobiotec represents companies and science & technology parks operating in Italy and involved in several sectors of life sciences.

Association’s resources

  • The Italian Biotech Industry: Economic Update 2018

    The aim of this report is to present an update of the key facts and figures of the Italian biotech industry.

    The report can be found here.

    See Publication
  • Italy – 2016 Report

    This report presents the key facts and data of the Italian biotech industry and provides a brief analysis of the current context within which Italian companies are operating.

    See Publication